About the Authors
- Dennie T. Frederick
-
Affiliation Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America
- Roberto A. Salas Fragomeni
-
Affiliations Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America
- Aislyn Schalck
-
Affiliation Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America
- Isabel Ferreiro-Neira
-
Affiliation Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America
- Taylor Hoff
-
Affiliation Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America
- Zachary A. Cooper
-
Affiliation Department of Surgical Oncology and Genomic Medicine, University of Texas, M.D.Anderson Cancer Center, Houston, Texas, United States of America
- Rizwan Haq
-
Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America
- David J. Panka
-
Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America
- Lawrence N. Kwong
-
Affiliation Department of Surgical Oncology and Genomic Medicine, University of Texas, M.D.Anderson Cancer Center, Houston, Texas, United States of America
- Michael A. Davies
-
Affiliation Department of Surgical Oncology and Genomic Medicine, University of Texas, M.D.Anderson Cancer Center, Houston, Texas, United States of America
- James C. Cusack
-
Affiliations Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America
- Keith T. Flaherty
-
Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America
- David E. Fisher
-
Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, United States of America
- James W. Mier
-
Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America
- Jennifer A. Wargo
-
Affiliation Department of Surgical Oncology and Genomic Medicine, University of Texas, M.D.Anderson Cancer Center, Houston, Texas, United States of America
- Ryan J. Sullivan
-
* E-mail: rsullivan7@partners.org
Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: DTF RAS JWM JAW RJS. Performed the experiments: DTF RAS AS TH ZC DJP LNK RJS IFN. Analyzed the data: DTF RAS AS RH LNK MAD JCC KTF DEF JWM JAW RJS IFN. Contributed reagents/materials/analysis tools: LNK MAD JCC KTF DEF JWM JAW RJS. Wrote the paper: DTF RAS AS ZC RH LNK KTF JAW RJS.